COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardle...
Envirotainer, the global market leader and by far the largest provider of secure cold chain solutions for air transport ...
The Australian government is preparing for the COVID-19 vaccine rollout by securing an additional vaccine workforce and ...
Pfizer Inc and BioNTech SE on Jan 20, 2021 announced results from an in vitro study that provides additional d...
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development an...
To support COVID-19 vaccination efforts, the Singapore government is setting up four COVID-19 vaccination centres this m...
Japan is aggressively making efforts to vaccinate its population for COVID-19 with a strong focus on signing pre-orders....
Among the four countries, Viet Nam has reached an agreement with the UK-based vaccine producer AstraZeneca to guarantee ...
The past few weeks have seen the regulatory approval of multiple safe and effective vaccines against Sars-CoV-2, the v...
The four leading international health and humanitarian organizations on Jan 12, 2021, announced the establishment of a g...
Merck, a leading science and technology company, on Jan 7, 2021 announced the acquisition of Am...
South Korean firm LG Chem has announced that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received Wor...
Ministry of Public Health Thailand has announced that it has secured the first 2 million doses of COVID-19 vac...
Indonesia is ready to initiate a nationwide COVID-19 mass vaccination program from mid-January2021.&nbs...
Cellid and the International Vaccine Institute (IVI) in South Korea have exchanged a collaborative research agreement to...
INOVIO, a US based biotechnology company focused on bringing to market precisely designed DNA medicines to treat and pro...
CIMC Enric Holdings has announced that its subsidiary Zhangjiagang CIMC Sanctum Cryogenic Equipment Co., Ltd recent...
By mid-2021, volunteers aged between 18 and 75 years will be recruited for an accelerated clinical trial of two ‘n...
